European Medical Journal Rheumatology : Impact Factor & More
eISSN: 2056-6395
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
European Medical Journal Rheumatology Journal Specifications
Indexed in the following public directories
DOAJ
| Overview | |
| Publisher | European Medical Journal |
| Language | English |
| Publication Time | 22 |
| Editorial Review Process | Double blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Publication Time | 22 |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in European Medical Journal Rheumatology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in European Medical Journal Rheumatology
How to Treat Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- 24 Jul 2025
- EMJ Rheumatology
Telerheumatology: Looking Beyond the Camera to Improve and Expand Access – A Narrative Review of eConsults in Rheumatology
- 24 Jul 2025
- EMJ Rheumatology
Birth-Related Factors and Risk of Juvenile Idiopathic Arthritis: Findings from Two Prospective, Nationwide, Norwegian Cohorts
- 24 Jul 2025
- EMJ Rheumatology
Long-Term Effect of Selexipag in Systemic Sclerosis-Associated Digital Ulcers: A Case Control, Multicentre, Observational Study
- 24 Jul 2025
- EMJ Rheumatology
Predicting Psoriatic Arthritis in New-Onset Psoriasis: Results from an Inception Cohort Study
- 24 Jul 2025
- EMJ Rheumatology
Comparison of the Efficacy of 12-Month Romosozumab Followed by 24-Month Denosumab Versus 36-Month Denosumab or Risedronate for Glucocorticoid-Induced Osteoporosis in Patients with Rheumatic Diseases: A Randomised Prospective Study
- 24 Jul 2025
- EMJ Rheumatology
How to Treat Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- 24 Jul 2025
- EMJ Rheumatology
Telerheumatology: Looking Beyond the Camera to Improve and Expand Access – A Narrative Review of eConsults in Rheumatology
- 24 Jul 2025
- EMJ Rheumatology
Birth-Related Factors and Risk of Juvenile Idiopathic Arthritis: Findings from Two Prospective, Nationwide, Norwegian Cohorts
- 24 Jul 2025
- EMJ Rheumatology
Long-Term Effect of Selexipag in Systemic Sclerosis-Associated Digital Ulcers: A Case Control, Multicentre, Observational Study
- 24 Jul 2025
- EMJ Rheumatology
Predicting Psoriatic Arthritis in New-Onset Psoriasis: Results from an Inception Cohort Study
- 24 Jul 2025
- EMJ Rheumatology
Comparison of the Efficacy of 12-Month Romosozumab Followed by 24-Month Denosumab Versus 36-Month Denosumab or Risedronate for Glucocorticoid-Induced Osteoporosis in Patients with Rheumatic Diseases: A Randomised Prospective Study
- 24 Jul 2025
- EMJ Rheumatology
FAQs on European Medical Journal Rheumatology
How many articles did European Medical Journal Rheumatology publish last year? 
Who is the publisher of European Medical Journal Rheumatology?
